RevOpsis and Kemwell Partner to Accelerate Development of RO-104 for nAMD

Partnership to accelerate development of lead product candidate, RO-104; a first-in-class tri-specific biologic for treating neovascular age-relat...

June 18, 2024 | Tuesday | News
New Dietary Guidelines Released to Combat Nutritional Challenges in India

The National Institute of Nutrition (NIN), under the Indian Council of Medical Research (ICMR), has released updated "Dietary Guide...

May 10, 2024 | Friday | Reports
Aragen’s Formulation Manufacturing Facility Achieves GMP Certification from Telangana Drugs Control Administration

Aragen is pleased to announce that its Formulation Manufacturing Facility (FMF) has been awarded Good Manufacturing Practice (GMP) certification by the Dru...

May 08, 2024 | Wednesday | News
SS Innovations' SSi Mantra System Completes First Infant Pyeloplasty in India

SS Innovations International, Inc., a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible t...

April 30, 2024 | Tuesday | News
President Smt Droupadi Murmu Introduces India's Historic Breakthrough in Cancer Treatment: Launches Groundbreaking Gene Therapy at IIT Bombay

India marked a historic milestone in its fight against cancer as President Smt Droupadi Murmu inaugurated the nation's inaugural homegrown ...

April 05, 2024 | Friday | News
Biocon Biologics Partners with Eris Lifesciences to Enhance Biosimilars Access in India

    Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON),...

March 14, 2024 | Thursday | News
Biocon Biologics Gains Rights to Launch Stelara® Biosimilar in the US by 2025 Following Janssen Settlement

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced...

March 04, 2024 | Monday | News
Takeda and Biological E. Limited Partner to Enhance Dengue Vaccine Availability in High-Risk Regions

Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per...

February 27, 2024 | Tuesday | News
Biocon Biologics and Sandoz Australia Forge Partnership for Biosimilars Trastuzumab and Bevacizumab

Biocon Biologics Ltd (BBL), a leading biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), has announced a significant five-ye...

February 09, 2024 | Friday | News
OmniActive Health Technologies Welcomes Amit Chopra as President and CEO

Amit Chopra, a seasoned professional with a proven track record in leadership, commercial strategies, manufacturing, mergers and acquisitions, and innovati...

February 02, 2024 | Friday | News
Glenmark Secures License Agreement for Envafolimab in Key Global Territories

Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East...

January 29, 2024 | Monday | News
Fujirebio and Agappe Ink CLIA Immunoassay Collaboration Agreement

In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progres...

January 19, 2024 | Friday | News
India's Government Issues Updated Schedule M to Strengthen Good Manufacturing Practices in the Pharmaceutical Industry

The issuance of the amended Schedule M follows persistent advocacy from industry associations such as the Organization of Pharmaceutical Producers of India...

January 08, 2024 | Monday | News
Piramal Pharma Solutions Inaugurates ADC Manufacturing Expansion in Grangemouth, Scotland

Ribbon cutting and commissioning of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing facility that expands capacity by approxi...

December 19, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close